Lilly Announces Details of Presentations at 2023 American Association for Cancer Research (AACR) Annual Meeting

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from its oncology portfolio will be presented at the American Association for...

Related Keywords

United States ,American ,Lauren Cohen ,Joe Fletcher ,Prnewswire Eli Lilly ,Eli Lilly ,Instagram ,Linkedin ,Lilly United States ,Laboratory Abnormalities ,Exchange Commission ,American Association For Cancer Research ,Facebook ,American Association ,Cancer Research ,Annual Meeting ,Novel Clinical ,Clinical Trials ,Poster Section ,Novel Hormonal Agent ,For Grade ,Grade Venous ,Prescribing Information ,Patient Information ,Atrial Flutter ,Primary Malignancies ,Fetal Toxicity ,Mantle Cell Lymphoma Who Received ,Special Populations ,Renal Impairment ,Forward Looking Statement ,Private Securities Litigation Reform Act ,United States Securities ,Eli Lilly And Company ,